Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsTOPICALStandard

ZILXI

MINOCYCLINE HYDROCHLORIDE

Standard Dose
EQ 1.5% BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: N/A Marketing status: Prescription
Summary

Approval overview ZILXI is listed in Drugs@FDA under application 213690 (NDA).

Review priority: N/A Marketing status: Prescription Active ingredient MINOCYCLINE HYDROCHLORIDE Form and strength AEROSOL, FOAM;TOPICAL - EQ 1.5% BASE Sponsor JOURNEY Submission history Latest submission status date: 2024-02-20 00:00:00.

Structured Monograph

Clinical summary

Approval overview ZILXI is listed in Drugs@FDA under application 213690 (NDA). Review priority: N/A Marketing status: Prescription Active ingredient MINOCYCLINE HYDROCHLORIDE Form and strength AEROSOL, FOAM;TOPICAL - EQ 1.5% BASE Sponsor JOURNEY Submission history Latest submission status date: 2024-02-20 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: N/A

Interaction Notes

  • No interaction notes stored yet.